Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (South Korea), South Korea, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
79%
Total
Publications
53
Total Open
Publications
42
Total
Citations
411
Open Access
Percentage
79%
Total
Publications
53
Total Open
Publications
42
Total
Citations
411
Breakdown
Publisher Open
49%
Both
30%
Other Platform Open
0%
Closed
21%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
16
Hybrid 36%
15
No Guarantees 26%
11
Other Platform Open
Domain 56%
9
Institution 44%
7
Public 25%
4
Other Internet 25%
4
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 9 |
Europe PMC | Domain | 6 |
Semantic Scholar | Public | 4 |
Yonsei University Medical Library - YUHSpace | Institution | 3 |
Unknown Repository | Other Internet | 2 |
Universidad de la Rioja - Dialnet | Institution | 2 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
Red Federada de Repositorios Institucionales de Publicaciones CientÃficas - LA Referencia | Other Internet | 1 |
Red Federada de Repositorios Institucionales de Publicaciones CientÃficas - LA Referencia | Institution | 1 |
OpenEdition - OpenEdition | Institution | 1 |